• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性免疫缺陷病(原发性免疫缺陷病)

Inborn errors of immunity (primary immunodeficiencies).

作者信息

Kim Vy H D, Upton Julia E M, Derfalvi Beata, Hildebrand Kyla J, McCusker Christine

机构信息

Division of Immunology and Allergy, Department of Pediatrics, The Hospital for Sick Children, Temerty School of Medicine, University of Toronto, Toronto, ON, Canada.

Division of Clinical Immunology and Allergy, Department of Medicine, Temerty School of Medicine, University of Toronto, Toronto, ON, Canada.

出版信息

Allergy Asthma Clin Immunol. 2025 Jan 8;20(Suppl 3):76. doi: 10.1186/s13223-024-00938-z.

DOI:10.1186/s13223-024-00938-z
PMID:39780212
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11714877/
Abstract

Primary immunodeficiencies (PID), now often referred to as inborn errors of immunity (IEI), are a large heterogeneous group of disorders that result from deficiencies in immune system development and/or function. IEIs can be broadly classified as disorders of adaptive immunity (e.g., combined or humoral immunodeficiencies) or of innate immunity (e.g., phagocyte and complement disorders). Although the clinical manifestations of IEIs are highly variable, traditionally many disorders involve an increased susceptibility to infection. Research in recent years has underscored how IEI can present with features other than infection such as: severe atopy, autoimmunity, autoinflammation, lymphoproliferation, and/or malignancy resulting from immune dysregulation. Early consultation with a clinical immunologist is essential, as timely diagnosis and treatment are imperative for preventing significant disease-associated morbidity and mortality. The treatment of IEIs is complex and generally requires both supportive and definitive strategies, including but not limited to, immunoglobulin replacement therapy, antibiotic prophylaxis, immune response modifiers, and hematopoietic stem cell transplantation. This article provides an overview of the major categories of IEIs and strategies for the appropriate diagnosis and management of these disorders.

摘要

原发性免疫缺陷病(PID),现在常被称为遗传性免疫缺陷(IEI),是一大类异质性疾病,由免疫系统发育和/或功能缺陷引起。遗传性免疫缺陷病可大致分为适应性免疫疾病(如联合免疫缺陷或体液免疫缺陷)或先天性免疫疾病(如吞噬细胞和补体疾病)。尽管遗传性免疫缺陷病的临床表现高度可变,但传统上许多疾病都表现出易感染性增加。近年来的研究强调了遗传性免疫缺陷病如何表现出感染以外的特征,如:严重特应性、自身免疫、自身炎症、淋巴细胞增殖和/或免疫失调导致的恶性肿瘤。尽早咨询临床免疫学家至关重要,因为及时诊断和治疗对于预防严重的疾病相关发病率和死亡率必不可少。遗传性免疫缺陷病的治疗很复杂,通常需要支持性和确定性策略,包括但不限于免疫球蛋白替代疗法、抗生素预防、免疫反应调节剂和造血干细胞移植。本文概述了遗传性免疫缺陷病的主要类别以及这些疾病的适当诊断和管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e3/11714877/9d403b7adf16/13223_2024_938_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e3/11714877/536d8023f0ae/13223_2024_938_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e3/11714877/59bdde321d7c/13223_2024_938_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e3/11714877/9d403b7adf16/13223_2024_938_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e3/11714877/536d8023f0ae/13223_2024_938_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e3/11714877/59bdde321d7c/13223_2024_938_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e3/11714877/9d403b7adf16/13223_2024_938_Fig3_HTML.jpg

相似文献

1
Inborn errors of immunity (primary immunodeficiencies).遗传性免疫缺陷病(原发性免疫缺陷病)
Allergy Asthma Clin Immunol. 2025 Jan 8;20(Suppl 3):76. doi: 10.1186/s13223-024-00938-z.
2
Primary immunodeficiency.原发性免疫缺陷
Allergy Asthma Clin Immunol. 2018 Sep 12;14(Suppl 2):61. doi: 10.1186/s13223-018-0290-5. eCollection 2018.
3
Primary immunodeficiency.原发性免疫缺陷病。
Allergy Asthma Clin Immunol. 2011 Nov 10;7 Suppl 1(Suppl 1):S11. doi: 10.1186/1710-1492-7-S1-S11.
4
Severity of SARS-CoV-2 infection in children with inborn errors of immunity (primary immunodeficiencies): a systematic review.患有先天性免疫缺陷(原发性免疫缺陷)儿童的新型冠状病毒2型感染严重程度:一项系统评价
Allergy Asthma Clin Immunol. 2023 Aug 9;19(1):69. doi: 10.1186/s13223-023-00831-1.
5
Future of Therapy for Inborn Errors of Immunity.免疫先天缺陷治疗的未来。
Clin Rev Allergy Immunol. 2022 Aug;63(1):75-89. doi: 10.1007/s12016-021-08916-8. Epub 2022 Jan 12.
6
Clinical updates in inborn errors of immunity: a focus on the noninfectious clinical manifestations.免疫缺陷相关临床进展:重点关注非感染性临床表现。
Curr Opin Pediatr. 2024 Apr 1;36(2):228-236. doi: 10.1097/MOP.0000000000001331. Epub 2024 Jan 22.
7
Inborn Errors of Immunity Presenting with Early-Onset Severe Atopy.以早发性严重特应性为表现的先天性免疫缺陷
Medicina (Kaunas). 2025 Jan 2;61(1):62. doi: 10.3390/medicina61010062.
8
When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders.怀疑 EBV 相关淋巴组织增生性疾病存在先天性免疫缺陷时该如何处理。
Clin Microbiol Infect. 2023 Apr;29(4):457-462. doi: 10.1016/j.cmi.2022.10.003. Epub 2022 Oct 6.
9
The Spectrum of Inborn Errors of Immunity in the United Arab Emirates: 5 Year Experience in a Tertiary Center.阿拉伯联合酋长国先天性免疫缺陷疾病谱:三级医疗中心的5年经验
Front Immunol. 2022 Jan 31;13:837243. doi: 10.3389/fimmu.2022.837243. eCollection 2022.
10
How I use allogeneic HSCT for adults with inborn errors of immunity.我如何使用异基因 HSCT 治疗成人先天性免疫缺陷。
Blood. 2021 Nov 4;138(18):1666-1676. doi: 10.1182/blood.2020008187.

本文引用的文献

1
Advances in gene therapy for inborn errors of immunity.免疫遗传性缺陷的基因治疗进展。
Curr Opin Allergy Clin Immunol. 2023 Dec 1;23(6):467-477. doi: 10.1097/ACI.0000000000000952. Epub 2023 Oct 13.
2
Treatment of inflammatory complications in common variable immunodeficiency (CVID): current concepts and future perspectives.常见可变免疫缺陷(CVID)炎症并发症的治疗:当前概念和未来展望。
Expert Rev Clin Immunol. 2023 Jun;19(6):627-638. doi: 10.1080/1744666X.2023.2198208. Epub 2023 Apr 6.
3
The Rapidly Expanding Genetic Spectrum of Common Variable Immunodeficiency-Like Disorders.
常见可变免疫缺陷样疾病的遗传谱迅速扩大。
J Allergy Clin Immunol Pract. 2023 Jun;11(6):1646-1664. doi: 10.1016/j.jaip.2023.01.048. Epub 2023 Feb 14.
4
Common Variable Immunodeficiency: More Pathways than Roads to Rome.普通可变免疫缺陷:条条大路通罗马。
Annu Rev Pathol. 2023 Jan 24;18:283-310. doi: 10.1146/annurev-pathmechdis-031521-024229. Epub 2022 Oct 20.
5
The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity.2022 年更新的人类先天性免疫缺陷疾病表型分类 IUIS
J Clin Immunol. 2022 Oct;42(7):1508-1520. doi: 10.1007/s10875-022-01352-z. Epub 2022 Oct 6.
6
Beyond Infections: New Warning Signs for Inborn Errors of Immunity in Children.超越感染:儿童遗传性免疫缺陷病的新警示信号
Front Pediatr. 2022 Jun 10;10:855445. doi: 10.3389/fped.2022.855445. eCollection 2022.
7
Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee.人类先天性免疫缺陷:国际免疫学联盟专家委员会 2022 年更新的分类。
J Clin Immunol. 2022 Oct;42(7):1473-1507. doi: 10.1007/s10875-022-01289-3. Epub 2022 Jun 24.
8
Atopy as Immune Dysregulation: Offender Genes and Targets.特应性作为免疫失调:罪犯基因和靶点。
J Allergy Clin Immunol Pract. 2022 Jul;10(7):1737-1756. doi: 10.1016/j.jaip.2022.04.001. Epub 2022 Jun 6.
9
Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network.全球杰弗里·莫德尔中心网络内原发性免疫缺陷病诊断与治疗的进展
Allergy Asthma Clin Immunol. 2022 Mar 4;18(1):19. doi: 10.1186/s13223-022-00662-6.
10
Primary immune regulatory disorders: Undiagnosed needles in the haystack?原发性免疫调节紊乱:未确诊的“大海捞针”?
Orphanet J Rare Dis. 2022 Mar 3;17(1):99. doi: 10.1186/s13023-022-02249-1.